NCT01852630View on ClinicalTrials.gov

Imipenem Versus Cefepime in Spontaneous Bacterial Peritonitis and to Evaluate the Risk Factors for Treatment Failure

NACompletedINTERVENTIONAL

Enrollment

175

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Spontaneous Bacterial Peritonitis

Interventions

DRUG

cefepime + Albumin

cefepime + Albumin will be given for 2 days

DRUG

Imipenem + Albumin

Imipenem + Albumin will be given for 2 days.

Trial Locations (1)

110070

Institute of Liver & Biliary Sciences (ILBS), New Delhi

All Listed Sponsors

lead

Institute of Liver and Biliary Sciences, India

OTHER

NCT01852630 - Imipenem Versus Cefepime in Spontaneous Bacterial Peritonitis and to Evaluate the Risk Factors for Treatment Failure | Biotech Hunter | Biotech Hunter